Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

921 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy.
Kobayashi N, Sunaga N, Yatomi M, Wakamatsu I, Muto S, Ikota H, Yamaguchi R, Ohtaki Y, Nagashima T, Kubo N, Masuda T, Miura Y, Tsurumaki H, Sakurai R, Koga Y, Hisada T, Maeno T. Kobayashi N, et al. Among authors: kubo n. Thorac Cancer. 2025 Jan;16(2):e15512. doi: 10.1111/1759-7714.15512. Epub 2024 Dec 27. Thorac Cancer. 2025. PMID: 39731296 Free PMC article.
Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations.
Kanbe M, Sunaga N, Hara K, Sawada H, Wakamatsu I, Hara K, Muto S, Sawada Y, Masubuchi H, Sato M, Miura Y, Tsurumaki H, Yatomi M, Sakurai R, Koga Y, Ohtaki Y, Nagashima T, Okano N, Kubo N, Maeno T, Hisada T. Kanbe M, et al. Among authors: kubo n. Thorac Cancer. 2022 Nov;13(22):3225-3228. doi: 10.1111/1759-7714.14678. Epub 2022 Oct 4. Thorac Cancer. 2022. PMID: 36193787 Free PMC article.
Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report.
Sunaga N, Miura Y, Sakurai R, Ohshima S, Uno S, Muto S, Sato M, Tsurumaki H, Yatomi M, Koga Y, Ohtaki Y, Nagashima T, Okano N, Kubo N, Maeno T, Hisada T. Sunaga N, et al. Among authors: kubo n. Anticancer Drugs. 2023 Apr 1;34(4):605-608. doi: 10.1097/CAD.0000000000001474. Epub 2022 Dec 5. Anticancer Drugs. 2023. PMID: 36729850
Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
Ohtaki Y, Nagashima T, Okano N, Kubo N, Ohtaka T, Sunaga N, Sakurai R, Miura Y, Nakazawa S, Kawatani N, Yazawa T, Yoshikawa R, Narusawa E, Shirabe K. Ohtaki Y, et al. Among authors: kubo n. Thorac Cancer. 2024 Apr;15(11):859-866. doi: 10.1111/1759-7714.15265. Epub 2024 Feb 27. Thorac Cancer. 2024. PMID: 38414316 Free PMC article.
Carbon-ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study.
Takayasu Y, Kubo N, Shino M, Nikkuni O, Ida S, Musha A, Takahashi K, Hirato J, Shirai K, Saitoh JI, Yokoo S, Chikamatsu K, Ohno T, Nakano T; Working Group on Head and Neck Tumors. Takayasu Y, et al. Among authors: kubo n. Cancer Med. 2019 Dec;8(17):7227-7235. doi: 10.1002/cam4.2614. Epub 2019 Oct 16. Cancer Med. 2019. PMID: 31621203 Free PMC article. Clinical Trial.
Response to Letter to the Editor.
Kubo N. Kubo N. J Thorac Oncol. 2024 Aug;19(8):e22. doi: 10.1016/j.jtho.2024.05.370. J Thorac Oncol. 2024. PMID: 39112007 No abstract available.
921 results